azathioprine has been researched along with Polyradiculoneuropathy, Chronic Inflammatory Demyelinating in 29 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating: A slowly progressive autoimmune demyelinating disease of peripheral nerves and nerve roots. Clinical manifestations include weakness and sensory loss in the extremities and enlargement of peripheral nerves. The course may be relapsing-remitting or demonstrate a step-wise progression. Protein is usually elevated in the spinal fluid and cranial nerves are typically spared. GUILLAIN-BARRE SYNDROME features a relatively rapid progression of disease which distinguishes it from this condition. (Adams et al., Principles of Neurology, 6th ed, p1337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We sought randomised and quasi-randomised trials of all immunosuppressive agents such as azathioprine, cyclophosphamide, methotrexate, ciclosporin A, mycophenolate mofetil, and rituximab and all immunomodulatory agents such as interferon alfa and interferon beta in participants fulfilling standard diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy." | 4.86 | Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. ( Hughes, RA; Mahdi-Rogers, M; Swan, AV; van Doorn, PA, 2010) |
| "We sought randomised and quasi-randomised trials of all immunosuppressive agents such as azathioprine, cyclophosphamide, methotrexate, cyclosporin A, mycophenolate mofetil, and rituximab and all immunomodulatory agents such as alpha interferon and beta interferon in participants fulfilling standard diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy." | 4.82 | Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy. ( Hughes, RA; Swan, AV; van Doorn, PA, 2003) |
| "We sought randomised and quasi-randomised trials of all immunosuppressive agents such as azathioprine, cyclophosphamide, methotrexate, cyclosporin A, mycophenolate mofetil, and rituximab and all immunomodulatory agents such as alpha interferon and beta interferon in participants fulfilling standard diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy." | 4.82 | Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy. ( Hughes, RA; Swan, AV; van Doorn, PA, 2004) |
| "Eighteen of them also had monoclonal gammopathy of undetermined significance (MGUS)." | 2.69 | Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. ( Ciano, C; Fallica, E; Mariotti, C; Pareyson, D; Sghirlanzoni, A; Solari, A, 2000) |
| "In addition, patients with typical CIDP were divided into two groups according to the first-line treatment modalities (group 1: IVIg only, group 2: IVIg + steroid)." | 1.91 | Pediatric-Onset Chronic Inflammatory Demyelinating Polyneuropathy: A Multicenter Study. ( Acar Arslan, E; Aksoy, A; Aksoy, E; Aliyeva, N; Ayanoğlu, M; Bektaş, Ö; Bodur, M; Canpolat, M; Çobanoğulları Direk, M; Gençpınar, P; Güleç, A; Gümüş, H; Gürkaş, E; Hız Kurul, S; Kanmaz, S; Keskin Yılmaz, S; Kızılırmak, AB; Kömür, M; Okuyaz, Ç; Olgaç Dündar, N; Öz Tuncer, G; Öztoprak, Ü; Öztürk, S; Per, H; Sarıkaya Uzan, G; Teber, S; Tekgül, H; Tosun, A; Ünalp, A; Ünay, B; Vural, A; Yıldırım, Ç; Yılmaz, Ü; Yiş, U; Yousefi, M; Yüksel, D, 2023) |
| "IR-CAP could well be 'axonal CIDP' in view of clinical similarity, but not proven as yet." | 1.56 | Chronic inflammatory axonal polyneuropathy. ( Alsharabati, M; King, P; Lu, L; Morgan, MB; Oh, SJ, 2020) |
| "Childhood chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare condition, and the optimal treatment strategy is not well established, especially in refractory cases." | 1.51 | Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory cases. ( Chae, JH; Choi, J; Choi, SA; Hwang, H; Kim, H; Kim, KJ; Kim, SY; Kim, W; Lim, BC; Shim, YK, 2019) |
| "Sixty-three CIDP patients were identified." | 1.46 | Clinical Characteristics and Treatment Response of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. ( Hanchaiphiboolkul, S; Suanprasert, N, 2017) |
| "Acute-onset CIDP resembles Guillain-Barre syndrome (GBS), a rapidly progressive disorder, and follows a chronic course." | 1.43 | Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: A case report. ( Choi, EH; Lim, JY; Lim, YH, 2016) |
| "Azathioprine was started." | 1.42 | CIDP variants in diabetes: measuring treatment response with a small nerve fiber test. ( Névoret, ML; Vinik, AI, 2015) |
| "To describe 31 children presenting a CIDP; to compare patients with rapid-onset disease vs." | 1.42 | Childhood CIDP: Study of 31 patients and comparison between slow and rapid-onset groups. ( Boulay, C; Cabasson, S; Meunier, A; Pedespan, JM; Rouanet-Larriviere, MF; Tardieu, M, 2015) |
| "In conclusion, CIDP is a clinically heterogeneous disorder." | 1.34 | Chronic inflammatory demyelinating polyneuropathy: a 6-year retrospective clinical study of a hospital-based population. ( Anyfanti, C; Ioannou, M; Kaponi, A; Pandis, D; Rentzos, M; Vassilopoulos, D, 2007) |
| "We present 4 patients with CIDP who required respiratory assistance and mechanical ventilation." | 1.33 | Chronic inflammatory demyelinating polyneuropathy and respiratory failure. ( Henderson, RD; Sandroni, P; Wijdicks, EF, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (44.83) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 6 (20.69) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, S | 1 |
| Lee, EK | 1 |
| Sohn, E | 1 |
| Sarıkaya Uzan, G | 1 |
| Vural, A | 1 |
| Yüksel, D | 1 |
| Aksoy, E | 1 |
| Öztoprak, Ü | 1 |
| Canpolat, M | 1 |
| Öztürk, S | 1 |
| Yıldırım, Ç | 1 |
| Güleç, A | 1 |
| Per, H | 1 |
| Gümüş, H | 1 |
| Okuyaz, Ç | 1 |
| Çobanoğulları Direk, M | 1 |
| Kömür, M | 1 |
| Ünalp, A | 1 |
| Yılmaz, Ü | 1 |
| Bektaş, Ö | 1 |
| Teber, S | 1 |
| Aliyeva, N | 1 |
| Olgaç Dündar, N | 1 |
| Gençpınar, P | 1 |
| Gürkaş, E | 1 |
| Keskin Yılmaz, S | 1 |
| Kanmaz, S | 1 |
| Tekgül, H | 1 |
| Aksoy, A | 1 |
| Öz Tuncer, G | 1 |
| Acar Arslan, E | 1 |
| Tosun, A | 1 |
| Ayanoğlu, M | 1 |
| Kızılırmak, AB | 1 |
| Yousefi, M | 1 |
| Bodur, M | 1 |
| Ünay, B | 1 |
| Hız Kurul, S | 1 |
| Yiş, U | 1 |
| Mehreen, S | 1 |
| Iftikhar, S | 1 |
| Muhammad, A | 1 |
| Aatif Siddique, R | 1 |
| Shahid, S | 1 |
| Kim, W | 1 |
| Shim, YK | 1 |
| Choi, SA | 1 |
| Kim, SY | 1 |
| Kim, H | 1 |
| Lim, BC | 1 |
| Hwang, H | 1 |
| Choi, J | 1 |
| Kim, KJ | 1 |
| Chae, JH | 1 |
| Muley, SA | 1 |
| Jacobsen, B | 1 |
| Parry, G | 1 |
| Usman, U | 1 |
| Ortega, E | 1 |
| Walk, D | 1 |
| Allen, J | 1 |
| Pasnoor, M | 1 |
| Varon, M | 1 |
| Dimachkie, MM | 1 |
| George, IC | 1 |
| Kvalsund, M | 1 |
| Saylor, D | 1 |
| Oh, SJ | 1 |
| Lu, L | 1 |
| Alsharabati, M | 1 |
| Morgan, MB | 1 |
| King, P | 1 |
| Mahdi-Rogers, M | 3 |
| Brassington, R | 1 |
| Gunn, AA | 1 |
| van Doorn, PA | 5 |
| Hughes, RA | 6 |
| Suanprasert, N | 1 |
| Hanchaiphiboolkul, S | 1 |
| Névoret, ML | 1 |
| Vinik, AI | 1 |
| Cabasson, S | 1 |
| Tardieu, M | 1 |
| Meunier, A | 1 |
| Rouanet-Larriviere, MF | 1 |
| Boulay, C | 1 |
| Pedespan, JM | 1 |
| Lim, JY | 1 |
| Lim, YH | 1 |
| Choi, EH | 1 |
| Oaklander, AL | 1 |
| Lunn, MP | 1 |
| van Schaik, IN | 1 |
| Frost, C | 1 |
| Chalk, CH | 1 |
| Otto, F | 1 |
| Neuen-Jacob, E | 1 |
| Arendt, G | 1 |
| Stüve, O | 1 |
| Hartung, HP | 1 |
| Swan, AV | 3 |
| Cocito, D | 1 |
| Grimaldi, S | 1 |
| Paolasso, I | 1 |
| Falcone, Y | 1 |
| Antonini, G | 1 |
| Benedetti, L | 1 |
| Briani, C | 1 |
| Fazio, R | 1 |
| Jann, S | 1 |
| Matà, S | 1 |
| Sabatelli, M | 1 |
| Nobile-Orazio, E | 1 |
| Pavesi, G | 1 |
| Cattaneo, L | 1 |
| Marbini, A | 1 |
| Gemignani, F | 1 |
| Mancia, D | 1 |
| Haq, RU | 1 |
| Pendlebury, WW | 1 |
| Fries, TJ | 1 |
| Tandan, R | 1 |
| Knecht, H | 1 |
| Baumberger, M | 1 |
| Tobòn, A | 1 |
| Steck, A | 1 |
| França, MC | 1 |
| de Castro, R | 1 |
| de Oliveira, MF | 1 |
| Garibaldi, SG | 1 |
| Nucci, A | 1 |
| de Souza Queiroz, L | 1 |
| Kraemer, MH | 1 |
| Henderson, RD | 1 |
| Sandroni, P | 1 |
| Wijdicks, EF | 1 |
| Rentzos, M | 1 |
| Anyfanti, C | 1 |
| Kaponi, A | 1 |
| Pandis, D | 1 |
| Ioannou, M | 1 |
| Vassilopoulos, D | 1 |
| Rossignol, E | 1 |
| D'Anjou, G | 1 |
| Lapointe, N | 1 |
| Haddad, E | 1 |
| Vanasse, M | 1 |
| Pedersen, K | 1 |
| Pandolfo, M | 1 |
| Mavroudakis, N | 1 |
| Reményi, P | 1 |
| Masszi, T | 1 |
| Borbényi, Z | 1 |
| Soós, J | 1 |
| Siklós, L | 1 |
| Engelhardt, JI | 1 |
| Sghirlanzoni, A | 1 |
| Solari, A | 1 |
| Ciano, C | 1 |
| Mariotti, C | 1 |
| Fallica, E | 1 |
| Pareyson, D | 1 |
6 reviews available for azathioprine and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
| Article | Year |
|---|---|
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Azathioprine; Humans; Immunoglobulins, Intravenous; Immunologic Factors; I | 2017 |
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Azathioprine; Humans; Immunologic Factors; Immunosuppressive Agents; Inter | 2013 |
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Topics: Adrenal Cortex Hormones; Azathioprine; Dexamethasone; Humans; Immunoglobulins, Intravenous; Immunosu | 2017 |
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Azathioprine; Humans; Immunologic Factors; Immunosuppressive Agents; Inter | 2010 |
Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunologic Factors; | 2003 |
Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunologic Factors; | 2004 |
1 trial available for azathioprine and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
| Article | Year |
|---|---|
Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Child; Cyclophosphamide; Electrophy | 2000 |
22 other studies available for azathioprine and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
| Article | Year |
|---|---|
Two Case Reports of Chronic Inflammatory Demyelinating Polyneuropathy After COVID-19 Vaccination.
Topics: 2019-nCoV Vaccine mRNA-1273; Ad26COVS1; Aged; Azathioprine; COVID-19; COVID-19 Vaccines; Guillain-Ba | 2023 |
Pediatric-Onset Chronic Inflammatory Demyelinating Polyneuropathy: A Multicenter Study.
Topics: Azathioprine; Child; Female; Humans; Immunoglobulins, Intravenous; Male; Methotrexate; Polyradiculon | 2023 |
Efficacy of azathioprine and methotrexate in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
Topics: Adolescent; Adult; Azathioprine; Humans; Immunosuppressive Agents; Methotrexate; Polyradiculoneuropa | 2023 |
Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory cases.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Glucoc | 2019 |
Rituximab in refractory chronic inflammatory demyelinating polyneuropathy.
Topics: Adult; Aged; Azathioprine; Canes; Cyclophosphamide; Female; Foot Orthoses; Glucocorticoids; Humans; | 2020 |
A case of combined central and peripheral demyelination in Zambia.
Topics: Adult; Azathioprine; Comorbidity; Demyelinating Diseases; Developing Countries; Glucocorticoids; Hum | 2020 |
Chronic inflammatory axonal polyneuropathy.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases of the Nervous System; Axons; Azathioprine; Biopsy; Chi | 2020 |
Clinical Characteristics and Treatment Response of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Topics: Adult; Aged; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunization, Passive; Immunos | 2017 |
CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Topics: Autonomic Nervous System; Azathioprine; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabet | 2015 |
Childhood CIDP: Study of 31 patients and comparison between slow and rapid-onset groups.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Child; Child, Preschool; Disease Progression; Ear | 2015 |
Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: A case report.
Topics: Acute Disease; Adult; Azathioprine; Carrier State; Coinfection; Exercise Therapy; Follow-Up Studies; | 2016 |
A 69-year-old man with left hemispheric necrotizing mass lesion.
Topics: Aged; Azathioprine; Brain; Brain Stem; Encephalitis, Viral; Epstein-Barr Virus Infections; Humans; I | 2009 |
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Axons; Azathioprine; Child; Cycloph | 2011 |
Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy.
Topics: Axons; Azathioprine; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Female; Hu | 2002 |
Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Topics: Adjuvants, Immunologic; Adult; Azathioprine; Diabetic Neuropathies; Female; Humans; Immunoglobulins, | 2003 |
Sustained remission of CIDP associated with Evans syndrome.
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclon | 2004 |
Long-standing idiopathic hypoparathyroidism masking coexistent chronic inflammatory demyelinating polyneuropathy.
Topics: Adolescent; Azathioprine; Calcium; Humans; Hypoparathyroidism; Immunoglobulins, Intravenous; Immunos | 2004 |
Chronic inflammatory demyelinating polyneuropathy and respiratory failure.
Topics: Aged; Azathioprine; Biopsy; Coma; Cyclophosphamide; Electromyography; Female; Follow-Up Studies; Hum | 2005 |
Chronic inflammatory demyelinating polyneuropathy: a 6-year retrospective clinical study of a hospital-based population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Biopsy; Demyelinating Diseases; Female; Gr | 2007 |
Evolution and treatment of childhood chronic inflammatory polyneuropathy.
Topics: Acute Disease; Adolescent; Azathioprine; Child; Child, Preschool; Disease Progression; Female; Gluco | 2007 |
Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment.
Topics: Azathioprine; Diabetic Neuropathies; Disease Progression; Female; Humans; Immunoglobulins, Intraveno | 2007 |
CIDP cured by allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Alopecia; Anemia, Aplastic; Azathioprine; Cyclophosphamide; Female; Graft vs Host Disease; He | 2007 |